Literature DB >> 12507389

Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.

Hideshi Fujita1, Takehiko Koji, Naoki Kitagawa, Keisuke Tsutsumi, Kuniko Abe, Makio Kaminogo, Shobu Shibata.   

Abstract

1. For a better understanding of the biological features of astrocytic tumors, we investigated apoptosis and its pathway, especially in the interaction between Fas and Fas ligand (FasL). 2. We examined the presence of apoptosis in human astrocytic brain tumors by terminal deoxynucleotidyl transferase (TdT)-mediated d-UTP-biotin nick end labeling (TUNEL) and then apoptotic index (AI) was calculated. We also examined the distribution of Fas and FasL-positive tumor cells immunohistochemically. Labeling index (LI) for Fas and FasL was calculated as Fas-LI and FasL-LI, respectively, and compared to AI. 3. Tumor cells expressing both Fas and FasL were TUNEL positive. Such cells were distributed sparsely in low-grade astrocytomas, but focally in glioblastomas. There was a close correlation among AI, Fas-LI, and FasL-LI, and astrocytic tumors with higher Al were associated with a longer survival time than that with lower Al. 4. It was concluded that the Fas system may be involved in the apoptosis of astrocytic tumors, and Al can be a useful parameter for assessing prognosis of astrocytic tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12507389     DOI: 10.1023/a:1021007503779

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  26 in total

1.  Tumor Fas (APO-1/CD95) up-regulation results in increased apoptosis and survival times for rats with intracranial malignant gliomas.

Authors:  B Frankel; S L Longo; M Kyle; G W Canute; T C Ryken
Journal:  Neurosurgery       Date:  2001-07       Impact factor: 4.654

2.  Clinical and biological considerations regarding glioma based on the TUNEL method and immunohistochemical staining using apoptosis-related antibodies.

Authors:  T Fujita; T Kayama
Journal:  Brain Tumor Pathol       Date:  1997       Impact factor: 3.298

3.  Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

Authors:  C Gratas; Y Tohma; E G Van Meir; M Klein; M Tenan; N Ishii; O Tachibana; P Kleihues; H Ohgaki
Journal:  Brain Pathol       Date:  1997-07       Impact factor: 6.508

4.  Heavy metal intensification of DAB-based HRP reaction product.

Authors:  J C Adams
Journal:  J Histochem Cytochem       Date:  1981-06       Impact factor: 2.479

5.  Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Authors:  P Saas; P R Walker; M Hahne; A L Quiquerez; V Schnuriger; G Perrin; L French; E G Van Meir; N de Tribolet; J Tschopp; P Y Dietrich
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

6.  Apoptosis and cell proliferation in human neuroepithelial tumors.

Authors:  D Schiffer; P Cavalla; A Migheli; A Chiò; M T Giordana; S Marino; A Attanasio
Journal:  Neurosci Lett       Date:  1995-08-04       Impact factor: 3.046

7.  Detection of DNA strand breaks associated with apoptosis in human brain tumors.

Authors:  S Nakagawa; T Shiraishi; S Kihara; K Tabuchi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins.

Authors:  D K Kim; J Hoyt; C Bacchi; G E Keles; M Mass; M R Mayberg; M S Berger
Journal:  Neurosurgery       Date:  1993-10       Impact factor: 4.654

9.  Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.

Authors:  D W Ellison; P V Steart; K C Gatter; R O Weller
Journal:  Neuropathol Appl Neurobiol       Date:  1995-08       Impact factor: 8.090

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.